spec sheet4 rows
Piracetam + Cinnarizine Omaron is a fixed combination of 400 mg piracetam and 25 mg cinnarizine, sold across the CIS for cerebrovascular complaints and vertigo.
- A fixed combination sold across the CIS for vertigo
- Cinnarizine carries a genuine antivertigo effect
- 400 mg piracetam and 25 mg cinnarizine per tablet
- Marketed for cerebrovascular complaints across the region
- Two established generics in one convenient tablet
Mechanism
Piracetam is a pyrrolidone that alters membrane fluidity and improves erythrocyte deformability at high doses; cinnarizine blocks T type calcium channels and H1 receptors, which is where the antivertigo effect comes from. The pairing is a commercial construct rather than a mechanistically designed combination.
Safetyrisks and cautions, not medical advice
the cinnarizine half is a dopamine antagonist that causes drug induced parkinsonism and tardive dyskinesia on prolonged use, particularly in older people
Subjective profileweighing the evidence above
A commercial pairing rather than a designed one, and the second half is the problem. Cinnarizine blocks dopamine receptors, and taken for months it causes parkinsonism and tardive dyskinesia in older people, which is exactly the group these cerebrovascular indications target; the movement disorder is routinely mistaken for the ageing it was prescribed to treat. Whatever piracetam is worth, it is available by itself, and there is no reason to accept a neuroleptic side profile as the price of getting it.
Where to buy
Suppliers
Vendors carrying Piracetam + Cinnarizine, with live product details and codes. Links are affiliate links that support the wiki at no cost to you.
RUPharma🌐
Piracetam + Cinnarizine